Pfizer reveals new Phase IV data to boost Chantix, Pristiq and Toviaz prospects
This article was originally published in Scrip
Executive Summary
"It's possible that patients might slip up and smoke while taking Chantix. If patients slip up, they can stay on Chantix and keep trying to quit," Pfizer optimistically said, announcing new post-marketing data for its smoking cessation product, varenicline (also marketed as Champix).